Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide plus Irinotecan in Advanced Gastric Cancer
NCT02401971Phase 4Unknown
- Start
- Aug 2014
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of thalidomide in gastric cancer (GC). Status: unknown.
02
Drugs
thalidomide
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT02401971.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02401971.